| SCHEDULE OF REPORTABLE SEGMENT LOSS |
The
following table presents reportable segment loss, including significant expenses regularly provided to the CODM, attributable to the
Company’s reportable segment for the years ended December 31, 2025 and 2024:
SCHEDULE OF REPORTABLE SEGMENT LOSS
| | |
2025 | | |
2024 | |
| | |
For the Year ended December 31, | |
| | |
2025 | | |
2024 | |
| Research and development: | |
| | | |
| | |
| External research and development | |
$ | 5,832,371 | | |
$ | 4,355,449 | |
| Internal personnel costs | |
| 3,508,588 | | |
| 2,895,648 | |
| Total research and development | |
| 9,340,959 | | |
| 7,251,097 | |
| General and administrative | |
| 10,492,554 | | |
| 8,114,654 | |
| Other income, net | |
| (138,018 | ) | |
| (343,724 | ) |
| Change in fair value of convertible promissory notes | |
| 1,153,421 | | |
| - | |
| Net loss | |
$ | 20,848,916 | | |
$ | 15,022,027 | |
|